According to a study, a tumor-lysing vaccinia virus that carries GM-CSF was found to successfully prevent CRC from spreading to the peritoneum by selectively infecting and lysing peritoneal tumor cells, as well as by activating peritoneal DCs and CD8 T cells to restore peritoneal anti-cancer immunity. This evidence concerns the gene CSF2 and neoplasm.